Today's pharmaceutical industry test professionals are looking for the latest information on sterile manufacturing as the development of new biopharmaceuticals have led to injectable product manufacturing, which requires faster, more stringent microbiological controls.
Today’s pharmaceutical industry test professionals are looking for the latest information on sterile manufacturing as the development of new biopharmaceuticals have led to injectable product manufacturing, which requires faster, more stringent microbiological controls.
Test professionals can hear the latest on the subject at Pharma Test Expo 2011, to be held next February 8-10, in Cologne, Germany.Dr Tim Sandle will speak on “Practical approaches to sterility testing” at the Pharma Test Expo 2011 Forums, where research and industry experts will be sharing the latest developments in the field of testing and quality assurance for pharmaceuticals.
Dr Sandle is the Head of Microbiology at the UK National Health Service Bio Products Laboratory. He is co-editor of the new book, Microbiology and Sterility Assurance in Pharmaceuticals and Medical Devices, which has been called “The gold standard for sterile manufacturing.”
Dr Sandle’s presentation will look at general difficulties associated with sterility test validation; consider practical approaches to products which are difficult to test; and provide an overview of those aspects of the sterility test which are not covered in the pharmacopoeias, along with current debates about the sterility test. Both the membrane filtration and direct inoculation methods will be covered.
Pharma Test Expo 2011 will be the forum of reference for the suppliers and users of pharmaceutical test equipment, instrumentation and outsourced services in the product development and manufacturing process. Don’t miss the chance to see and hear the latest at the first fair dedicated exclusively to testing and quality assurance in the pharmaceuticals industry.
Pharma Test Expo
8,9, 10 February 2011
Koelnmesse, Cologne, Germany
Contact
David Stradling
Direct Tel: +44 (0) 1306 803032
Fax: +44 (0) 1306 803034
Email: d.stradling@hulst-expo.comhttp://www.pharmatestexpo.com/
Transformations in Drug Development for Cell and Gene Therapies
March 28th 2025As a recognized leader in immunophenotyping for clinical trials, Kevin Lang from PPD discusses how spectral flow cytometry is transforming drug development, particularly in cell and gene therapies like CAR-T. He also dives into his award-winning research, including his 2024 WRIB Poster Award-winning work, and his insights from presenting at AAPS PharmSci360.
The Role of Forced Degradation in Method Development, Manufacturability, and CMC Strategy
April 28th 2025Forced degradation studies are critical in biologics development, particularly for monoclonal antibodies (mAbs). These studies simulate long-term environmental stressors to uncover degradation pathways and ensure the stability of critical quality attributes (CQAs), aiding in robust chemistry, manufacturing, and controls (CMC) strategies and regulatory compliance.
Advancing Clinical Trials with Spectral Flow Cytometry: A Conversation with Kevin Lang
March 28th 2025As a recognized leader in immunophenotyping for clinical trials, Kevin Lang from PPD discusses how spectral flow cytometry is transforming drug development, particularly in cell and gene therapies like CAR-T. He also dives into his award-winning research, including his 2024 WRIB Poster Award-winning work, and his insights from presenting at AAPS PharmSci360.